
Vir Biotechnology, Inc.
Vir Biotechnology, Inc. (VIR)
WebsitePrice
Market cap
Next catalystExpected Q1 2027Elebsiran and tobevibart — CHD clinical programme · Phase 3 dataCompany source ↗
Cash
Chart & Events
Core Clinical
PreINDP1P2P3FilingApproved
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
PreINDP1P2P3FilingApproved
Other pipelines
Approved / commercial
History / paused
PreINDP1P2P3FilingApproved
PreINDP1P2P3FilingApproved